BUDGET IMPACT OF ALECTINIB IN THE TREATMENT OF NAIVE ANAPLASTIC LYMPHOMA
KINASE-POSITIVE (ALK plus ) ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
IN GREECE
BUDGET IMPACT OF ALECTINIB IN THE TREATMENT OF NAIVE ANAPLASTIC LYMPHOMA KINASE-POSITIVE (ALK plus ) ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) IN GREECE